EZH2 inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EZH2 inhibitor, covering 2024-12-02 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer. [Phase 2]